To explore the possibility that MCC is expressed in clinical brain cancer samples, total tissue lysates of normal and glioblastoma tissues derived from patients during surgery were analyzed by immunoblotting using an anti-MCC antibody. The gene discussed is MCC; the disease is brain cancer.